Damon Vidrine, Gina DeNicola, and Matthew Schabath named research leaders at Moffitt

After the stunning success of mRNA vaccines during the COVID-19 pandemic, researchers and biotech companies are racing to prove the utility of the technology in an array of non-communicable diseases—including cancer, cystic fibrosis, and sickle cell disease.